Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00132912
Status:
COMPLETED
Last Update Posted:
2017-05-25
First Post:
2005-08-19
Brief Title:
Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention Study P03573
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The object of the study is to determine whether different doses of SCH 530348 when added to standard medical care in persons undergoing percutaneous coronary intervention will increase the risk of bleeding
A secondary objective is to determine whether patients treated with SCH 530348 have fewer cardiac events such as heart attack bypass surgery or death compared with those persons treated with the standard of care
A secondary objective is to determine whether patients treated with SCH 530348 have fewer cardiac events such as heart attack bypass surgery or death compared with those persons treated with the standard of care
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None